Joint Pharmacy Drug Importation Letter
NABP, National Organizations Release Statement on Ensuring Diversity, Equity, and Inclusion in Health Care
Fighting Fake Medicines Sold Online Requires Commitment to Cautioning Patients
December 4, 2023 Falsified and substandard medicine harms patients, potentially causing disease progression, adverse events, and even death. When patients buy medicine from an illegal online pharmacy, these negative outcomes are definite possibilities. In today’s post-pandemic era, when consumers shop online for everything including medicine, it is critical for patients to understand the risks associated […]
Read More ›Building a Sustainable, Healthy Pharmacy Workforce and Workplace
The Tri-Regulator Collaborative Position Statement on Interprofessional, Team-based Patient Care
October 1, 2013 As the leading organizations representing the licensing boards of the United States that regulate the practice of medicine, pharmacy, and nursing, the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) express our support for interprofessional collaboration and a […]
Read More ›The Tri-Regulator Collaborative Position Statement on Practice Location for Consumer Protection
March 1, 2014 As the organizations representing the state and territorial licensing boards in the United States that regulate the practice of medicine, pharmacy and nursing, the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) affirm that in a consumer protection […]
Read More ›NABP Issues Policy Statement Supporting the Pharmacist’s Role in Increasing Access to Opioid Overdose Reversal Drug
October 20, 2014 As the opioid overdose epidemic continues to take hundreds of lives each week, the National Association of Boards of Pharmacy® (NABP®) has issued a policy statement promoting an active role for pharmacists in expanding access to the opioid overdose reversal drug, naloxone. Nearly 17,000 people died from an overdose involving an opioid analgesic […]
Read More ›Tri-Regulator Collaborative Release Position Statements Addressing Electronic Health Records, Practitioner Burnout
September 20, 2017 The Tri-Regulator Collaborative, the governing boards of the three organizations representing the state boards that license physicians, nurses, and pharmacists – the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) – have drafted and approved two position statements […]
Read More ›NCPO Statement on Combatting the Opioid Crisis
January 31, 2018 The National Conference of Pharmaceutical Organizations (NCPO) is a coalition of organizations and associations that represents the discovery, manufacture, and distribution of medications and practitioners that provide effective patient care. Collectively, our organizations represent over 300,000 individual pharmacy practitioners and pharmaceutical scientists, companies engaged in diverse aspects of healthcare delivery, and the […]
Read More ›Statement on Prescription Drug Importation Proposals
February 1, 2019 Prescription Drug Importation is Not a Viable Solution to High Prescription Drug Costs Policymakers, rightfully so, have sought to lower prescription drug costs for ordinary Americans. Some of the proposals being considered would allow for importation of prescription drugs from other countries where they are currently being sold at cheaper prices. These […]
Read More ›